Edition:
India

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

60.97USD
1:30am IST
Change (% chg)

$1.26 (+2.11%)
Prev Close
$59.71
Open
$60.28
Day's High
$61.57
Day's Low
$60.01
Volume
66,609
Avg. Vol
79,880
52-wk High
$106.23
52-wk Low
$57.26

Select another date:

Thu, Sep 26 2019

Enanta Pharma's NASH drug meets mid-stage study goal

Enanta Pharmaceuticals Inc said on Wednesday its drug to treat non-alcoholic steatohepatitis (NASH) met the main goal of reducing levels of elevated liver enzymes in a mid-stage study.

UPDATE 1-Enanta Pharma's NASH drug meets mid-stage study goal

Sept 25 Enanta Pharmaceuticals Inc said on Wednesday its drug to treat non-alcoholic steatohepatitis (NASH) met the main goal of reducing levels of elevated liver enzymes in a mid-stage study.

Enanta Pharma's liver disease drug meets mid-stage study goal

Sept 25 Enanta Pharmaceuticals Inc said on Wednesday its drug to treat non-alcoholic steatohepatitis (NASH) met the main goal of reducing levels of elevated liver enzymes in a mid-stage study.

Enanta's lung infection therapy succeeds in mid-stage trial

Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.

UPDATE 1-Enanta's lung infection therapy succeeds in mid-stage trial

June 14 Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.

REFILE-Enanta's lung infection therapy succeeds in mid-stage trial

June 14 Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body and improving symptoms in patients in a mid-stage study.

Select another date: